Patent · US Active

Methods and compositions for immunotherapy of cancer

US7794729B2 · kind B2 · utility

20Cited by
23References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 24, 2004
Grant dateSep 14, 2010
Priority date
Expiry dateMay 30, 2026

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2760/16122
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention includes compositions, methods and kits for inducing an immune response to a tumor and for treating cancer with a Listeria vaccine strain expressing an antigen fused to a truncated LLO protein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.